Characterization of the use of antiemetic agents in dogs with parvoviral enteritis treated at a veterinary teaching hospital: 77 Cases (1997-2000)

Journal of the American Veterinary Medical Association

Volumn 227, Issue 11, 2005, Pages 1787-1793

  Mantione, Nina L ^a   Otto, Cynthia M ^b  

^a Good Hope Animal Hospital   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIEMETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; METOCLOPRAMIDE; ONDANSETRON; PROCHLORPERAZINE; VIRUS VACCINE;

BREATHING RATE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOG; ENTERITIS; FEMALE; HEART RATE; HOSPITALIZATION; HYPOTENSION; IMMUNOMODULATION; LEUKOCYTE COUNT; MALE; NONHUMAN; PARVOVIRUS; RECTUM TEMPERATURE; RETROSPECTIVE STUDY; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TEACHING HOSPITAL; TREATMENT OUTCOME; VETERINARY MEDICINE; VIRUS INFECTION; VOMITING;

ANIMALS; ANTIEMETICS; DOG DISEASES; DOGS; ENTERITIS; FEMALE; HOSPITAL MORTALITY; HOSPITALS, ANIMAL; LENGTH OF STAY; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, CANINE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VOMITING;

ANIMALIA; CANINE PARVOVIRUS; CANIS FAMILIARIS; PARVOVIRUS;

EID: 28444467721     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.227.1787     Document Type: Review

References (25)

1. Prittie J. Canine parvoviral enteritis: a review of diagnosis, management, and prevention. J Vet Emerg Crit Care 2004;14:167-176.
2. Washabau RJ, Elie MS. Antiemetic therapy. In: Kirk RW, ed. Current veterinary therapy XII. Philadelphia: WB Saunders Co, 1995; 679-684.
3. Hall JA, Washabau RJ. Gastrointestinal prokinetic therapy: dopaminergic antagonist drugs. Compend Contin Educ Pract Vet 1997; 19:214-221.
4. DiPalma JR. Metoclopramide: a dopamine receptor antagonist. Am Fam Physician 1990;41:919-924.
5. Rallis TS, Papazoglou LG, Adamama-Moraitou KK, et al. Acute enteritis or gastroenteritis in young dogs as a predisposing factor for intestinal intussusception: a retrospective study. J Vet Med Physiol Pathol Clin Med 2000;47:507-511.
6. Washabau RJ, Hall JA. Diagnosis and management of gastrointestinal motility disorders in dogs and cats. Compend Contin Educ Pract Vet 1997;19:721-737.
7. Macartney L, McCandlish IA, Thompson H, et al. Canine parvovirus enteritis 2: pathogenesis. Vet Rec 1984;115:453-460.
8. Otto CM, Drobatz K, Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occuring parvoviral enteritis. J Vet Intern Med 1997;11:65-70.
9. King LG. Postoperative complications and prognostic indicators in dogs and cats with septic peritonitis: 23 cases (1989-1992). J Am Vet Med Assoc 1994;204:407-414.
10. Houston DM, Ribble CS, Head LL. Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982-1991). J Am Vet Med Assoc 1996;208:542-546.
11. Tonini M, Cipollina L, Poluzzi E, et al. Review article: clinical implications of enteric and central D2 receptor blockade by anti-dopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 2004;19:379-390.
12. Zhu XH, Zellweger R, Wichmann MW, et al. Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis. Cytokine 1997;9:437-446.
13. Oberbeck R, Schmitz D, Wilsenack K, et al. Metoclopramide and cellular immune functions during polymicrobial sepsis. Eur Surg Res 2004;36:116-122.
14. Oberbeck R, Schmitz D, Wilsenack K, et al. Prolactin modulates survival and cellular immune functions in septic mice. J Surg Res 2003;113:248-256.
15. MacGregor EA. Anti-emetics. Curr Med Res Opin 2001; 17(suppl 1):s22-s25.
16. Pesola GR, Quinto C. Prochlorperazine-induced neuroleptic malignant syndrome. J Emerg Med 1996;14:727-729.
17. Koseoglu V, Kurekci AE, Sarici U, et al. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. Eur J Pediatr 1998;157:806-810.
18. Fukui H, Yamamoto M. Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy. Eur J Phannacol 1999;372:261-267.
19. Mohr AJ, Leisewitz AL, Jacobson LS, et al. Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis. J Vet Intern Med 2003;17:791-798.
20. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
21. Hauptman JG, Walshaw R, Olivier NB. Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet Surg 1997;26:393-397.
22. Hardie EM. Life-threatening bacterial infection. Compend Contin Educ Pract Vet 1995;17:290-302.
23. Okano S, Yoshida M, Fukushima U, et al. Usefulness of systemic inflammatory response syndrome criteria as an index for prognosis judgement. Vet Rec 2002;150:245-246.
24. Welzl C, Leisewitz AL, Jacobson LS, et al. Systemic inflammatory response syndrome and multiple-organ damage/dysfunction in complicated canine babesiosis. J S Afr Vet Assoc 2001;72: 158-162.
25. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-538.